The Prescription Pill Didn’t Cure My Yeast Infection

Monistat_treats_ 5 out of 5 yeast infections

When it comes to treating a vaginal yeast infection, you want to stop symptoms like itching, burning, and irritation in their tracks, while choosing a treatment that you know will actually cure the infection. The thing is, yeast infections can be caused by many different types of yeast. And not all treatments are effective against all types of yeast. The prescription pill only treats 3 out of the 5 most common types of yeast, so it may not cure your infection. Let’s take a closer look…

What’s the Deal with Different Types of Yeast?

The most common type of yeast is called Candida albicans. There are also a variety of other non-albicans species. MONISTAT® is effective for albicans and nearly all non-albicans species of yeast, and it treats a broader spectrum of infections than the leading prescription. In fact, recent data from the International Society for the Study of Vulvovaginal Disease (ISSVD) shows that miconazole, the active ingredient in MONISTAT®, is the only recommended azole treatment for the most prevalent non-albicans yeast species.

5 out of 5…It’s a No-Brainer

Get back to enjoying life without the discomfort and annoyance of a yeast infection—or the question of whether the treatment you chose will cure the infection. MONISTAT® provides the broadest treatment of yeast infections1,2, treating 5 out of 5 of the most common types of yeast—that’s even more than the leading prescription, which only treats 3 out of 5. Plus, it relieves symptoms 4x faster and is available over-the-counter: no need to visit your doctor to start treating symptoms now.

 

References

  1. Richter SS et al., Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J Clin Microbiol. 2005;43(5):2155-2162.
  2. ISSVD. (2016). Vulvovaginal Candidiasis (Candida, Yeast): Tips for Diagnosis and Treatment (Version 1.0) [Mobile application software]. Retrieved from http://itunes.apple.com
Topics: